Submitted by itadmin on
Precision medicine applied to breast cancer has traditionally drawn up patient profiles with the use of techniques such as genomic sequencing and microarrays. Over the past decade, proteomics research has achieved breakthroughs in the identification and quantification of certain biomarkers in clinical samples, which help stratify patients by the sub-type of breast cancer that they develop.
Submitted by itadmin on
When the Human Proteome Project (HPP) was launched in 2010, the scientific community viewed it as “a global initiative to build a map of all human proteins and their involvement in diseases,” says Dr Manuel Fuentes from the Cancer Research Institute of Salamanca.
Submitted by itadmin on
According to a report by the Spanish Society of Medical Oncology (SEOM), colorectal cancer is the cancer with the highest incidence rate (15%) in both sexes in Spain.
Submitted by itadmin on
Almost 150 years ago, T.R. Ashworth first described the presence of epithelial cells in the blood of a woman with metastatic breast cancer, which were very similar in appearance to her primary tumour cells.